Skip to main content
Caplight Logo









VentriNaya

VentriNaya

Private
New York City, New YorkHealthcare & Life Scienceshttps://ventrinaya.com/

Last Round

Accelerator

Nov 11, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

VentriNaya is a biotechnology company developing scalable, off-the-shelf regenerative gene and cell therapy platforms to treat cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

gene therapycell therapyregenerative medicinecardiac regenerationstem cell therapyheart tissue repairmyocardial infarctionheart failure treatmentoff-the-shelf therapycardiovascular diseasepreclinical biotechCyclin A2 therapyplacental stem cells

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VentriNaya Comparables

Compare VentriNaya with similar companies based on industry and business-model similarity.

VentriNaya comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medera
84%
Jaan Biotherapeutics
84%
StemCardia
82%

VentriNaya Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorNov 11, 2025

VentriNaya Investors

Notable investors and investment history

VentriNaya investors
InvestorRounds
Cure by DeerfieldAccelerator
Qatar Development BankAccelerator
Qatar Investment AuthorityAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2025

    Raised an Accelerator round with Qatar Investment Authority and Cure by Deerfield.

VentriNaya Filings

Explore SEC and related filing metadata, where available.

VentriNaya filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about VentriNaya's valuation, stock price, and market status.

Is VentriNaya a public or private company?

VentriNaya is a private company.

What is the current stock price of VentriNaya?

VentriNaya is a private company with no public stock price. No recent secondary market data is available.

How much is VentriNaya worth (valuation)?

Valuation information for VentriNaya is not publicly available.

Can I buy VentriNaya stock?

VentriNaya shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was VentriNaya's last funding round?

VentriNaya's most recent funding round was Accelerator on November 11, 2025.

Who are the main investors in VentriNaya?

Key investors in VentriNaya include Cure by Deerfield, Qatar Development Bank, Qatar Investment Authority.

Will VentriNaya IPO soon?

No public IPO plans have been announced for VentriNaya.

How can I track VentriNaya secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VentriNaya's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Year FoundedN/A
Last FundingNov 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?